Biotech Investment Analyst — Drug Asset & Company Assessment

Job description

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.

**Responsibilities**

- Create and critique rubrics that analyze commercial drugs and drug-development programs

- Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers

- Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions

- Apply your assessment across the pilot's set of companies (~5–10)

**Requirements**

- US-based biotech / healthcare investment analyst with a specialist-fund background

- Familiarity with biotech/pharma development programs

- Able to assess a drug asset and the company behind it end-to-end

- 5+ years evaluating biotech/pharma companies or assets

**Engagement Details**

- Duration: Approximately 10–20 hours over a 1–2 week pilot

- Remote — US-based

**Why Participate**

- Help improve expert AI evaluation of drugs and drug-development programs

- Recurring engagement for strong contributors